Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1

被引:127
作者
Weihofen, Andreas [1 ,2 ]
Ostaszewski, Beth [1 ,2 ]
Minami, Yasufumi [3 ]
Selkoe, Dennis J. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Inst Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Maebashi Inst Technol, Dept Biotechnol, Gunma 3710816, Japan
关键词
D O I
10.1093/hmg/ddm334
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the ubiquitously expressed gene PTEN-induced kinase 1 (Pink1) cause autosomal recessive Parkinson's disease. Pink1 encodes a putative serine/threonine kinase with an N-terminal mitochondrial targeting sequence. The mechanism that leads to selective degeneration of dopaminergic neurons via Pink1 mutations is unknown. A full-length pre-protein (66 kDa) and an N-terminally truncated mature form (55 kDa) have been described in human brain. Here, we report that the endogenous 66 kDa and 55 kDa Pink1 forms in cultured cells are not exclusive to mitochondria but also occur in cytosolic and microsome-rich fractions. Pink1 66 kDa is the predominant isoform in cultured cells. Using unbiased analyses of immunoisolated Pink1 complexes by mass spectrometry, co-immunoprecipitation and Hsp90 inhibitor studies, we identify Pink1 as a novel Cdc37/Hsp90 client kinase. This chaperone system influences both the subcellular distribution and the 66/55 kDa protein ratio of Pink1. PD-causing Pink1 mutations decrease whereas Parkin expression increases the Pink1 66/55 kDa protein ratio, biochemically linking Pink1 and Parkin and highlighting the potential relevance of this ratio for PD pathogenesis. Finally, we document the influence of Parkin on Pink1 subcellular distribution, providing further evidence for a common pathogenic pathway in recessive PD.
引用
收藏
页码:602 / 616
页数:15
相关论文
共 35 条
[1]   Pharmacological prevention of Parkinson disease in Drosophila [J].
Auluck, PK ;
Bonini, NM .
NATURE MEDICINE, 2002, 8 (11) :1185-1186
[2]   Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability [J].
Beilina, A ;
Van Der Brug, M ;
Ahmad, R ;
Kesavapanyt, S ;
Miller, DW ;
Petsko, GA ;
Cookson, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (16) :5703-5708
[3]   Molecular chaperones and protein kinase quality control [J].
Caplan, Avrom J. ;
Mandal, Atin K. ;
Theodoraki, Maria A. .
TRENDS IN CELL BIOLOGY, 2007, 17 (02) :87-92
[4]   Mitochondrial fusion and fission in mammals [J].
Chan, David C. .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2006, 22 :79-99
[5]   Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin [J].
Clark, Ira E. ;
Dodson, Mark W. ;
Jiang, Changan ;
Cao, Joseph H. ;
Huh, Jun R. ;
Seol, Jae Hong ;
Yoo, Soon Ji ;
Hay, Bruce A. ;
Guo, Ming .
NATURE, 2006, 441 (7097) :1162-1166
[6]   Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y [J].
Deng, H ;
Jankovic, J ;
Guo, Y ;
Xie, WJ ;
Le, WD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 337 (04) :1133-1138
[7]   PINK1 protein in normal human brain and Parkinson's disease [J].
Gandhi, S. ;
Muqit, M. M. K. ;
Stanyer, L. ;
Healy, D. G. ;
Abou-Sleiman, P. M. ;
Hargreaves, I. ;
Heales, S. ;
Ganguly, M. ;
Parsons, L. ;
Lees, A. J. ;
Latchman, D. S. ;
Holton, J. L. ;
Wood, N. W. ;
Revesz, T. .
BRAIN, 2006, 129 :1720-1731
[8]  
Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661
[9]  
Hadden MK, 2006, CURR TOP MED CHEM, V6, P1173
[10]   Genetics of Parkinson's disease and parkinsonism [J].
Hardy, John ;
Cai, Huaiban ;
Cookson, Mark R. ;
Gwinn-Hardy, Katrina ;
Singleton, Andrew .
ANNALS OF NEUROLOGY, 2006, 60 (04) :389-398